Home › Companies › Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical › Ratio Therapeutics
Ratio Therapeutics
Ratio Therapeutics is a clinical phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Ratio Therapeutics is a company in biopharma, biotechnology, life science, medical, pharmaceutical based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2021.
Ratio Therapeutics is positioned in biopharma, biotechnology, life science, medical, pharmaceutical, a segment that rewards a clear, focused offering.
The company is recorded as being based in Greater Boston Area, East Coast, New England, Northeastern US.
The company is listed at the Series_B stage of development.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $90M in funding.
| Sector | Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $90,000,000 |
Website: ratiotx.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account